Vetoquinol History

Vétoquinol is a family-owned, independent company exclusively and passionately devoted to improving animal health and encompasses research and development, manufacturing, marketing and sales.

Since 1933, veterinarians have benefited from Vétoquinol's acknowledged expertise, particularly in the fields of anti-infectives, anti-inflammatories and cariodlogy-nephrology. Based in France, Vétoquinol currently puts its products at the disposal of the 5 continents, thanks to its subsidiaries in 21 countries and its network of 110 distributors.
 
From big ideas to a big company

Landmarks in this family-owned company, now headed by the founder’s son, Etienne Frechin.
 2008.
- Creation of a development unit in Canada
- Acquisition of Viavet in Scandinavia
- Launch of Vetprofen® (anti-inflammatory) and Rubenal® (cariodlogy-nephrology)
 
2007.
- Vétoquinol Unipessoal Lda created in Portugal
- Launch of Alfaxan® (anesthetic)
 
2006.       
- Acquisition of Semyung Vet in South Korea and Vet Solutions in the USA
- Listed on Paris stock market
- Launch of Marbocyl® S (antibiotic), Dolpac® (antiparasitic) and Flexadin (chondroprotective agent)
 
2005.      
- Launch of Clavaseptin® (a palatable antibiotic for dogs and cats)
 
2004.     
- Sales office opened in China, for Asia-South Pacific
- Debut of company’s new strapline: "Sign of Passion"
 
2003.      
- Launch of Propalin® (treatment for urinary incontinence in ovariectomised bitches) and Marbocyl® P (antibiotic in palatable tablets form
- New premises in France double the amount of space for Research & Development
 
2002.
- Evsco and Tomlyn ranges bought from IGI Inc. in the USA
- Launch of Prilium® (canine cardiology)
 
2001.
- Acquisition of Swiss-based group Chassot and subsidiaries in Europe
- Launch of Aurizon® (treatment for otitis in dogs)
 
1999.      
- Acquisition of J. Webster in Canada
 
1998.      
- Acquisition of MECA in Germany
 
1995.       
- Launches of Marbocyl® (anti-infective) in Europe
 
1992.
- Vétoquinol Mexico founded
- Acquisition of Austin and Dispar in Canada
 
1991.      
- Acquisition of Antibioticos Pharma Vet in Spain
 
1990.    
- Vétoquinol North America founded in Canada
- Acquisition of Multivet and MVE in Canada and Univet in the UK
 
1987
- First launch of Tolfedine® (anti-inflammatory)
 
1984       
Galvet Ltd founded in Ireland
 
1980
Research & Development centre opened
 
1977       
Vetam, first subsidiary, founded in the Netherlands
 
1962       
- "Vétoquinol S.A" founded
- Arrival of Étienne Frechin, son of Joseph Frechin, and current President
 
1933       
- The „Laboratoires Biochimiques de l’Est“ founded by Joseph Frechin, doctor of pharmacology, in Lure, France

- Development of the first quinoline-based veterinary product: Vétoquinol